✦ LIBER ✦

Simvastatin + ciprofibrate for CAD and FCHL

Book ID: 120878622
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1997
Weight: 253 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199710710-00025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simvastatin: implications for CAD risk m

Simvastatin: implications for CAD risk management

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Comparison of simvastatin and ciprofibra

Comparison of simvastatin and ciprofibrate in the treatment of primary hypercholesterolaemia — a French multicentre study

✍ M Farnier 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 679 KB

Effect of treatment with gemfibrozil or

Effect of treatment with gemfibrozil or simvastatin of patients with familial combined hyperlipidemia (FCHL) on LDL subfraction profile and LDL oxidizability

✍ S.J.H. Bredie; P.N.M. Demacker; T.W.A. de Bruin; J.J.P. Kastelein; A.F.H. Stalen 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 158 KB

CAD'04 Special Issue: modeling and geome

CAD'04 Special Issue: modeling and geometry representations for CAD

✍ Les A. Piegl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 37 KB

and Exhibition was held in the land of smiles, Thailand, May 24-28. Topics for paper presentation covered a large spectrum ranging from numerical control, through design for manufacturing, to applications in biology and jewelry design. Based on the recommendations of the Advisory Board, two special

Fine mapping ofHyplip1and the human homo

Fine mapping ofHyplip1and the human homolog, a potential locus for FCHL

✍ Päivi Pajukanta, Jackie S. Bodnar, Riitta Sallinen, Michael Chu, Tuula Airaksine 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 499 KB

RISC for CAD and CIM

📂 Article 📅 1986 🏛 Elsevier Science ⚖ 190 KB